China Biologic Committee To Weigh $4.59B Take-Private Bid
By Elise Hansen ( September 24, 2019, 1:51 PM EDT) -- China Biologic's board of directors has formed a special committee to review a $4.59 billion take-private proposal, the biopharmaceutical company said Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.